Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial
Titel:
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial
Auteur:
Ismael, Gustavo Hegg, Roberto Muehlbauer, Susanne Heinzmann, Dominik Lum, Bert Kim, Sung-Bae Pienkowski, Tadeusz Lichinitser, Mikhail Semiglazov, Vladimir Melichar, Bohuslav Jackisch, Christian